Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

Bibliographic Details
Main Authors:	Xin Huang, Hao Ran, Yingkai Li, Qian Ma, Changyi Ou, Li Qiu, Huiyu Feng, Weibin Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Neurology
Subjects:	myasthenia gravis leflunomide low dose prednisone Th1 cells Th2 cells Th17 cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1179017/full

Similar Items

Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
by: Xin Huang, et al.
Published: (2022-09-01)

Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China
by: Xin Huang, et al.
Published: (2018-02-01)

Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway
by: Shuwen Pei, et al.
Published: (2021-12-01)

MYOID CELL OF THE HUMAN THYMUS: A STRANGER IN THE NIGHT OF MYASTHENIA GRAVIS
by: Andrei Dragoș Cumpănaș1,, et al.
Published: (2018-07-01)

An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis
by: Yong Peng, et al.
Published: (2024-02-01)

Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients
by: Zhiguo Peng, et al.
Published: (2023-11-01)

T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells
by: Wenjuan Wang, et al.
Published: (2020-08-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)

Research progress on the role of transcription factor T-bet in the pathogenesis of chronic obstructive pulmonary disease
by: CHEN Yuting, HUANG Ling, XIA Junjie, QIU Yu, YI Ke, WANG Jincheng
Published: (2023-08-01)

Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study
by: Ping Jiang, et al.
Published: (2022-05-01)

Novel Immunotherapies for Myasthenia Gravis
by: Nair SS, et al.
Published: (2023-04-01)

Delayed diagnosis of distal myasthenia gravis: a case report
by: M. L. Cao, et al.
Published: (2024-11-01)

Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis
by: Xiaoyu Huang, et al.
Published: (2025-01-01)

FMT rescues mice from DSS-induced colitis in a STING-dependent manner
by: Dan Pu, et al.
Published: (2024-12-01)

Transcriptional landscape of myasthenia gravis revealed by weighted gene coexpression network analysis
by: Demin Zhang, et al.
Published: (2023-03-01)

Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in Mice
by: Tang S, et al.
Published: (2019-11-01)

Clinical characteristics of late-onset myasthenia gravis
by: Chenjing Sun, et al.
Published: (2024-04-01)

Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease
by: Cristina Dumitru, et al.
Published: (2018-03-01)

The role of Th/Treg immune cells in osteoarthritis
by: Zhi Wen, et al.
Published: (2024-09-01)

A HYPOKALEMIA CASE RES?STANT TO TREATMENT ASSOCIATED WITH LEFLUNOMIDE
by: GÜLALİ AKTAŞ, et al.
Published: (2014-08-01)

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
by: Ruksana Huda
Published: (2020-02-01)

T-helper cells and their cytokines in pathogenesis and treatment of asthma
by: Tingfen Ji, et al.
Published: (2023-06-01)

Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study
by: Huahua Zhong, et al.
Published: (2022-08-01)

Myasthenia gravis and related disorders : 11th International Conference /
by: Kaminski, Henry J., et al.
Published: (2008)

Pathology of asthma
by: Makoto eKudo, et al.
Published: (2013-09-01)

Thymectomy in 19 Cases of Myasthenia Gravis in 4 Years Follow up
by: Saeed Mahmoudi, et al.
Published: (2002-09-01)

Differentiation and function of human monocyte-derived dendritic cells under the influence of leflunomide
by: Stojić-Vukanić Z., et al.
Published: (2011-01-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021)

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
by: Zhaohui Ni, et al.
Published: (2021-01-01)

T helper cell subsets and related target cells in acute COVID-19
by: I. V. Kudryavtsev, et al.
Published: (2022-07-01)

LEFLUNOMIDE IN RHEUMATOID ARTHRITIS: URGENT MATTERS OF PRACTICAL USE
by: Yuri Aleksandrovich Olyunin
Published: (2009-09-01)

Downregulation of HMGB1 in thymoma cells affects T cell differentiation
by: Jian Li, et al.
Published: (2023-09-01)

Increased circulating Th22 cells correlated with Th17 cells in patients with severe preeclampsia
by: Zhan Zhang, et al.
Published: (2017-01-01)

Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021-11-01)

Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
by: Pan Wang, et al.
Published: (2024-06-01)

Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
by: Stefan Quasthoff
Published: (2024-11-01)

Clinical characteristics and outcomes of COVID-19 infection among myasthenia gravis patients in a national referral hospital in Indonesia
by: Fitri Octaviana, et al.
Published: (2023-09-01)

Miastenia grave y miastenia grave ocular
by: Rosa María Naranjo Fernández, et al.

Cellular plasticity of CD4+ T cells in the intestine
by: Verena eBrucklacher-Waldert, et al.
Published: (2014-10-01)

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities
by: Chi Ma, et al.
Published: (2024-05-01)